Six strengths — 2.5, 5, 7.5, 10, 12.5 and 15 mg — supplied in single-dose vials.
Same day of the week, subcutaneous injection into thigh or abdomen.
2.5, 5, 7.5, 10, 12.5, and 15 mg — supporting individualised titration.
Each vial delivers one dose. Do not reuse vials, syringes, or needles.
A dual GIP and GLP-1 receptor agonist administered once weekly by subcutaneous injection. gojaro solution should be clear, colourless to slightly yellow. Do not use if the medicine appears cloudy, has particles, or is discoloured.
Each strength is identified by its cap colour — quick to recognise on the shelf and in your fridge.
Use only the strength recommended for you. Do not combine vials to make up a dose.
Type 2 diabetes and obesity affect a large share of the global adult population.
Global prevalence estimates for adults.
Store unused vials in a refrigerator, in the original carton to protect from light. If needed, an unopened vial may be kept at room temperature (below 30°C) for up to 21 days. Do not freeze.
Each vial contains a single dose only. Do not reuse a vial, syringe, or needle. Do not share your vial, syringe, or needles with other people — you may transmit a serious infection.
A weekly calendar, an injection-site rotation guide, and answers to the questions most people ask.
See resources →This site provides information about gojaro (tirzepatide) for healthcare professionals and patients who have been prescribed the medicine. It is not medical advice. Always follow the guidance of your prescriber. If you experience a serious side effect, contact your healthcare provider immediately.